Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Danesi

Showing results (61-70 of 160) with videos related to

Pageof 16
Sort By:
Agents and Actions|January 1, 1993
Macrolide antibiotics as antiinflammatory agents: roxithromycin in an unexpected roleC Agen, R Danesi, C Blandizzi, et al.
British Journal of Cancer|July 30, 2005
Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cellsG Bocci, A Fioravanti, P Orlandi, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1994
Pharmacokinetics and tolerance of nicotinamide combined with radiation therapy in patients with glioblastoma multiformeF Cartei, R Danesi, F Ducci, et al.
Toxicology and Applied Pharmacology|December 13, 2001
Acetylcholinesterase blockade does not account for the adverse cardiovascular effects of the antitumor drug irinotecan: a preclinical studyC Blandizzi, B De Paolis, R Colucci, et al.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1990
Superoxide anion production by doxorubicin analogs in heart sarcosomes and by mitochondrial NADH dehydrogenaseP G Gervasi, M R Agrillo, A Lippi, et al.
British Journal of Cancer|February 9, 2005
Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profileE Giovannetti, V Mey, R Danesi, et al.
Cardiologia (Rome, Italy)|June 1, 1992
[The antianginal effects of a new delayed-release formulation of diltiazem in patients with stable angina pectoris: its evaluation by the ergometry test and dynamic electrocardiogram]M Metra, A Catalano, R Danesi, et al.
Cardiologia (Rome, Italy)|June 1, 1991
[The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure]S Nodari, M Metra, P Gei, et al.
Toxicology|January 1, 1991
Cardiotoxicity and cytotoxicity of the anthracycline analog 4'-deoxy-4'-iodo-doxorubicinR Danesi, N Bernardini, C Agen, et al.
Therapeutic Drug Monitoring|June 12, 1999
An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasmaS Fogli, R Danesi, F Innocenti, et al.
Pageof 16

Showing results (61-70 of 160) with videos related to

Sort By:
Pageof 16
Agents and Actions|January 1, 1993
Macrolide antibiotics as antiinflammatory agents: roxithromycin in an unexpected roleC Agen, R Danesi, C Blandizzi, et al.
British Journal of Cancer|July 30, 2005
Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cellsG Bocci, A Fioravanti, P Orlandi, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1994
Pharmacokinetics and tolerance of nicotinamide combined with radiation therapy in patients with glioblastoma multiformeF Cartei, R Danesi, F Ducci, et al.
Toxicology and Applied Pharmacology|December 13, 2001
Acetylcholinesterase blockade does not account for the adverse cardiovascular effects of the antitumor drug irinotecan: a preclinical studyC Blandizzi, B De Paolis, R Colucci, et al.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1990
Superoxide anion production by doxorubicin analogs in heart sarcosomes and by mitochondrial NADH dehydrogenaseP G Gervasi, M R Agrillo, A Lippi, et al.
British Journal of Cancer|February 9, 2005
Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profileE Giovannetti, V Mey, R Danesi, et al.
Cardiologia (Rome, Italy)|June 1, 1992
[The antianginal effects of a new delayed-release formulation of diltiazem in patients with stable angina pectoris: its evaluation by the ergometry test and dynamic electrocardiogram]M Metra, A Catalano, R Danesi, et al.
Cardiologia (Rome, Italy)|June 1, 1991
[The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure]S Nodari, M Metra, P Gei, et al.
Toxicology|January 1, 1991
Cardiotoxicity and cytotoxicity of the anthracycline analog 4'-deoxy-4'-iodo-doxorubicinR Danesi, N Bernardini, C Agen, et al.
Therapeutic Drug Monitoring|June 12, 1999
An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasmaS Fogli, R Danesi, F Innocenti, et al.
Pageof 16